These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12091844)

  • 1. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.
    Maier RF; Obladen M; Müller-Hansen I; Kattner E; Merz U; Arlettaz R; Groneck P; Hammer H; Kössel H; Verellen G; Stock GJ; Lacaze-Masmonteil T; Claris O; Wagner M; Matis J; Gilberg F;
    J Pediatr; 2002 Jul; 141(1):8-15. PubMed ID: 12091844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis.
    Kotto-Kome AC; Garcia MG; Calhoun DA; Christensen RD
    J Perinatol; 2004 Jan; 24(1):24-9. PubMed ID: 14726934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of erythropoietin in premature infants.
    Amin AA; Alzahrani DM
    Saudi Med J; 2002 Mar; 23(3):287-90. PubMed ID: 11938417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
    Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG;
    Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants.
    Schneider JK; Gardner DK; Cordero L
    Pharmacotherapy; 2008 Nov; 28(11):1335-40. PubMed ID: 18956993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants.
    Türker G; Sarper N; Gökalp AS; Usluer H
    Am J Perinatol; 2005 Nov; 22(8):449-55. PubMed ID: 16283605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants.
    Haiden N; Schwindt J; Cardona F; Berger A; Klebermass K; Wald M; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Nov; 118(5):2004-13. PubMed ID: 17079573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A management guideline to reduce the frequency of blood transfusion in very-low-birth-weight infants.
    Rabe H; Alvarez JR; Lawn C; Seddon P; Amess PN
    Am J Perinatol; 2009 Mar; 26(3):179-83. PubMed ID: 19085812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines.
    Badiee Z; Pourmirzaiee MA; Kelishadi R; Naseri F
    Saudi Med J; 2006 Jun; 27(6):817-20. PubMed ID: 16758042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and prematurity--where do we stand?
    Carbonell-Estrany X; Figueras-Aloy J; Alvarez E
    J Perinat Med; 2005; 33(4):277-86. PubMed ID: 16207112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out.
    Ohls RK
    J Pediatr; 2002 Jul; 141(1):3-6. PubMed ID: 12091842
    [No Abstract]   [Full Text] [Related]  

  • 17. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group.
    Maier RF; Obladen M; Kattner E; Natzschka J; Messer J; Regazzoni BM; Speer CP; Fellman V; Grauel EL; Groneck P; Wagner M; Moriette G; Salle BL; Verellen G; Scigalla P
    J Pediatr; 1998 May; 132(5):866-70. PubMed ID: 9602202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with human recombinant erythropoietin and frequency of retinopathy of prematurity].
    Rudzińska IM; Kornacka MK; Pawluch R
    Przegl Lek; 2002; 59 Suppl 1():83-5. PubMed ID: 12108083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.